Lightnews — Scholar-powered news

Reposted by Yüksel Ürün

OncoDaily @oncodaily.bsky.social · 2d

Global Cancer Burden Calls for Action on Prevention and Equity - Yüksel Ürün

@yukselurun.bsky.social

oncodaily.com/voices/yukse...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Yüksel Ürün: Global Cancer Burden Calls for Action on Prevention and Equity - OncoDaily

Yüksel Ürün: Global Cancer Burden Calls for Action on Prevention and Equity / cancer, OncoDaily, Oncology, Yüksel Ürün

oncodaily.com

1 3

Yüksel Ürün @yukselurun.bsky.social · 4d

Proud to join such inspiring colleagues as an #ESMOAmbassadors
Excited for #ESMO25 and all the new #CancerResearch ahead.
@myesmo.bsky.social

ESMO - European Society for Medical Oncology @myesmo.bsky.social · 4d

@ptarantinomd.bsky.social ; @yukselurun.bsky.social ; @arndtvogel.bsky.social ; @tiansterzhangmd.bsky.social

3

Reposted by Yüksel Ürün

ESMO - European Society for Medical Oncology @myesmo.bsky.social · 4d

@ptarantinomd.bsky.social ; @yukselurun.bsky.social ; @arndtvogel.bsky.social ; @tiansterzhangmd.bsky.social

1 3

Yüksel Ürün @yukselurun.bsky.social · 4d

Hastalarımıza gerçeği anlatmak.
Ne korku satmak, ne de sahte umut vermek.

Medya, veriyi dürüst anlattığında güç katar. Ama çarpıtılmış grafikler, abartılmış başlıklar, seçilmiş veriler…
Korku yaratır. Umudu kirletir.

Gerçeği savunmak, hastalarımızı korumaktır. Veri konuşsun, biz dinleyelim.

Yüksel Ürün @yukselurun.bsky.social · 7d

Cancer care often forgets those at the edges: teens, elders, people with rare cancers. Their needs don’t fit the standard path. Fertility, intimacy, body image deserve the same care as the tumor.
@oncoalert.bsky.social @oncoassist.bsky.social

2

Yüksel Ürün @yukselurun.bsky.social · 12d

Every patient is first a human being with a name, a story, a dream.
Dignity is part of the treatment.
Never reduce a life to a diagnosis…
@ascocancer.bsky.social
@myesmo.bsky.social
@oncoalert.bsky.social

2

Yüksel Ürün @yukselurun.bsky.social · 14d

Proud of our rising star Coşkun and all colleagues. This meta-analysis on PARP inhibitors and thrombosis risk asks the right question for patients.
@oncoalert.bsky.social @myesmo.bsky.social @apccc.bsky.social @drchoueiri.bsky.social @neerajagarwal.bsky.social

1 1

Yüksel Ürün @yukselurun.bsky.social · 27d

“Medice, cura te ipsum”
Doctor, heal yourself.
Even healers burn out.
Rest is not weakness, it is repair.
Caring for others starts with caring for yourself.

@oncoalert.bsky.social @oncbrothers.bsky.social @ascocancer.bsky.social @myesmo.bsky.social

1 2

Reposted by Yüksel Ürün

OncoDaily @oncodaily.bsky.social · Sep 11

Dr. Yüksel Ürün’s Highlights from VIRO 2025 on Personalizing Treatment in the Frontline Setting

@yukselurun.bsky.social

oncodaily.com/pulse/dr-yuk...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #VIRO #VIRO25

Dr. Yüksel Ürün’s Highlights from VIRO 2025 on Personalizing Treatment in the Frontline Setting - OncoDaily

Dr. Yüksel Ürün at VIRO 2025 shares insights on personalizing frontline kidney cancer treatment, emphasizing biology and patient-centered care.

oncodaily.com

1 2

Reposted by Yüksel Ürün

OncoDaily @oncodaily.bsky.social · Sep 9

Join Us for Global Voices in Renal Oncology Virtual Congress 2025

@yukselurun.bsky.social

oncodaily.com/pulse/global...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

4 9

Yüksel Ürün @yukselurun.bsky.social · Sep 8

Global voices, shared hope.
Excited to join colleagues at VIRO 2025—working together for patients in renal cancer.

#OncoDaily #VIRO2025
@oncodaily.bsky.social
docs.google.com/forms/d/e/1F...

3

Reposted by Yüksel Ürün

OncoDaily @oncodaily.bsky.social · Aug 20

🌍 𝗚𝗹𝗼𝗯𝗮𝗹 𝗩𝗼𝗶𝗰𝗲𝘀 𝗶𝗻 𝗥𝗲𝗻𝗮𝗹 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆 (𝗩𝗜𝗥𝗢) 𝗩𝗶𝗿𝘁𝘂𝗮𝗹 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀
📅 Sept 11–12, 2025 | 🩺 Chaired by Dr. Rana McKay & co-chaired by Dr. Yüksel Ürün
@yukselurun.bsky.social

🔗 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗳𝗼𝗿 𝗳𝗿𝗲𝗲: forms.gle/qcQyaGMQfHDh...

oncodaily.com/pulse/rana-m...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd

1 6

Reposted by Yüksel Ürün

OncoDaily @oncodaily.bsky.social · Aug 22

Meet the Experts of VIRO 2025 - Yüksel Ürün

@yukselurun.bsky.social

oncodaily.com/pulse/yuksel...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Yüksel Ürün: Meet the Experts of VIRO 2025

Prof. Yüksel Ürün is a distinguished Professor of Medical Oncology at Ankara University School of Medicine and one of Turkey’s leading experts in

oncodaily.com

1 6

Reposted by Yüksel Ürün

OncoDaily @oncodaily.bsky.social · Aug 26

Liquid Biopsy Is No Longer the Future - Yüksel Ürün

@yukselurun.bsky.social
@neerajagarwal.bsky.social
@euplatinum.bsky.social

oncodaily.com/science/liqu...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #LiquidBiopsy

Yüksel Ürün: Liquid Biopsy Is No Longer the Future - OncoDaily

Yüksel Ürün: Liquid Biopsy Is No Longer the Future / Antonio Alcaraz, Benjamin L Maughan, cancer, Emmanuel S Antonarakis, genitourinary malignancies, Lars

oncodaily.com

1 6

Reposted by Yüksel Ürün

OncoDaily @oncodaily.bsky.social · Aug 30

Cancer Prevention is the Quiet Revolution - Yüksel Ürün

@yukselurun.bsky.social

oncodaily.com/voices/yukse...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Yüksel Ürün: Cancer Prevention is the Quiet Revolution - OncoDaily

Yüksel Ürün: Cancer Prevention is the Quiet Revolution / cancer, Cancer Prevention, Cancer research, OncoDaily, Oncology, Yüksel Ürün

oncodaily.com

1 4

Yüksel Ürün @yukselurun.bsky.social · Aug 8

Every patient teaches me something new about strength, hope, and why we fight.

1 2

Reposted by Yüksel Ürün

OncoDaily @oncodaily.bsky.social · Jul 13

Science Is Better When It’s Shared - Yüksel Ürün
@yukselurun.bsky.social

oncodaily.com/blog/science...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Science

Yüksel Ürün: Science Is Better When It’s Shared - OncoDaily

Yüksel Ürün: Science Is Better When It’s Shared / cancer, Headlines, OncoDaily, Oncology, Yüksel Ürün

oncodaily.com

2 9

Reposted by Yüksel Ürün

OncoDaily @oncodaily.bsky.social · Jul 15

Breast Cancer Care Shouldn’t Be a Luxury - Yüksel Ürün
@yukselurun.bsky.social

oncodaily.com/insight/yuks...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #BreastCancer

Yüksel Ürün: Breast Cancer Care Shouldn’t Be a Luxury - OncoDaily

Yüksel Ürün: Breast Cancer Care Shouldn’t Be a Luxury / Amal Arahmani, Ander Urruticoechea, Ankara University School of Medicine, Barbro Lindholm, Boon H.

oncodaily.com

2 10

Reposted by Yüksel Ürün

Priya Patel @priyapatei.bsky.social · Jul 26

This sounds like an exciting step forward! How soon do you think cancer vaccines like these could become more widely used?

1 1

Reposted by Yüksel Ürün

OncoDaily @oncodaily.bsky.social · Jul 27

A Promising Option for Non–Non-Clear-Cell Renal Cell Carcinoma - Yüksel Ürün
@yukselurun.bsky.social
@euplatinum.bsky.social

oncodaily.com/science/yuks...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #nccRCC #KidneyCancer

Yüksel Ürün: A Promising Option for Non–Clear-Cell Renal Cell Carcinoma - OncoDaily

Yüksel Ürün: A Promising Option for Non–Clear-Cell Renal Cell Carcinoma / cancer, Craig Gedye, Cristina Suárez, David Pook, Erhan Gokmen, european urology,

oncodaily.com

1 8

Reposted by Yüksel Ürün

OncoDaily @oncodaily.bsky.social · Aug 5

How Should We Treat mCRPC and HRR Deficiency? - Yüksel Ürün

@yukselurun.bsky.social

oncodaily.com/blog/how-sho...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #mCRPC #HRR #ProstateCancer

Yüksel Ürün: How Should We Treat mCRPC and HRR Deficiency? - OncoDaily

Yüksel Ürün: How Should We Treat mCRPC and HRR Deficiency? / Ankara University School of Medicine, cancer, HRR Deficiency, mCRPC, metastatic

oncodaily.com

1 6

Reposted by Yüksel Ürün

OncoDaily @oncodaily.bsky.social · Jul 4

First Positive Phase 3 Trial for a Bispecific ADC - Paolo Tarantino
@ptarantinomd.bsky.social
@yukselurun.bsky.social

oncodaily.com/insight/paol...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ADC

Paolo Tarantino: First Positive Phase 3 Trial for a Bispecific ADC - OncoDaily

Paolo Tarantino: First Positive Phase 3 Trial for a Bispecific ADC / ADCs, Biokin Pharma, BMS, cancer, Minhua Chu, OncoDaily, Oncology, Paolo Tarantino,

oncodaily.com

2 9

Yüksel Ürün @yukselurun.bsky.social · Jul 2

Cancer vaccines: the next frontier is now.
From HBV & HPV to personalized mRNA shots
@oncoalert.bsky.social @oncoassist.bsky.social @ptarantinomd.bsky.social @drchoueiri.bsky.social @viveksubbiah.bsky.social

1 1 4

Yüksel Ürün @yukselurun.bsky.social · Jun 19

Take care of your kidneys, protect your life.
4 simple actions = less risk, better outcomes:
🚭 Quit smoking
⚖️ Stay at a healthy weight
🏃‍♀️ Be active, avoid trauma
💧 Drink water, skip alcohol
Because prevention is power
@oncoalert.bsky.social
@drchoueiri.bsky.social @kidneycan.bsky.social

1 3

Yüksel Ürün @yukselurun.bsky.social · Jun 15

🎗 Gerçek bilim bazen zor konuşur.
Herkes “mucize” ister, ama biz sabırla örülmüş gerçekleri anlatırız.

📌 Evet, süreç yorucu.
📌 Evet, sonuç her zaman adil değil.
Ama geçmişe göre çok daha iyiyiz.
Birçok tümörde, yıllar kazandıran tedaviler var artık

1